Expert Voices in Dementia

In this episode, Emily Clionsky, MD, a physician board certified in psychiatry and neurology, and Mitchell Clionsky, PhD, a board-certified clinical neuropsychologist, discuss their initial evaluative approach and work-up for a patient with suspected cognitive impairment. The Clionskys are principals of Clionsky Neuro Systems in Springfield, MA and co-authors of Dementia Prevention: Using Your Head to Save Your Brain. Learn more about your ad choices. Visit megaphone.fm/adchoices

Daniel C. Potts, MD, FAAN, Attending Neurologist at the Tuscaloosa VA Medical Center speaks with Marie Marley, PhD, author of the award-winning book Come Back Early Today: A Memoir of Love, Alzheimer's and Joy. They discuss practical steps neurologists can take to clearly and compassionately deliver traumatic diagnoses and how best to provide informed advice which ultimately helps patients continue living well with cognitive impairment. Learn more about your ad choices. Visit megaphone.fm/adchoices

Daniel C. Potts, MD, FAAN, Attending Neurologist at the Tuscaloosa VA Medical Center speaks with Marie Marley, PhD, author of the award-winning book Come Back Early Today: A Memoir of Love, Alzheimer's and Joy. They discuss their journey as respective caregivers and also offer helpful recommendations and resources designed to help neurologists partner with and support caregivers. Learn more about your ad choices. Visit megaphone.fm/adchoices

Kyra O'Brien, MD, Assistant Professor of Neurology at the Hospital of the University of Pennsylvania discusses modifiable barriers to performing cognitive evaluations in primary care based on the results of the study, Clinician-reported Factors Influencing Performance of Cognitive Evaluations in Primary Care. Learn more about your ad choices. Visit megaphone.fm/adchoices

Ana C. Pereira, MD, Associate Professor, Icahn School of Medicine at Mount Sinai, New York, NY, discusses key takeaways about the impact of patient lifestyle modifications on brain health, updates in biomarkers and disease-modifying therapies, and new frontiers in Alzheimer disease research based on research presented at the 2025 meeting of the Alzheimer’s Association International Conference (AAIC). Learn more about your ad choices. Visit megaphone.fm/adchoices

Gregory E. Cooper, MD, PhD, Director, Memory Center, Norton Neuroscience Institute, Louisville, KY, outlines the Brain Health Navigator program as a strategy to streamline dementia care pathways, ensuring earlier diagnosis and faster access to disease-modifying therapies. This program, developed by the Davos Alzheimer’s Collaborative, is designed to reduce system inefficiencies across primary and specialty care and improve access for all patients. Learn more about your ad choices. Visit megaphone.fm/adchoices

This episode explores groundbreaking qualitative research from the University of Pennsylvania on patient and caregiver perspectives in Alzheimer disease. Dr. Katie Auriemma, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, and Dr. Carolyn Chow, Penn Medicine, Philadelphia, PA, discuss findings from interviews with patients and caregivers that reveal hopes, worries, and nuanced views on AD therapies—highlighting the importance of patient-centered outcomes, shared decision-making, and aligning treatment with family goals. Learn more about your ad choices. Visit megaphone.fm/adchoices

In this episode, we are joined by entrepreneur and television personality, Barbara Corcoran. While many know Barbara for her business acumen and dynamic presence on Shark Tank, fewer may know the deeply personal and powerful story she shares today—her nine-year journey as a caregiver for her mother, who lived with Alzheimer disease. In this heartfelt conversation, Barbara opens up about the early signs her family overlooked, the emotional toll of watching her mother's personality shift, and the pivotal moment that changed their approach to caregiving. From practical strategies to navigate agitation in Alzheimer disease, to profound lessons in empathy, patience, and family dynamics, Barbara’s story offers inspiration and wisdom for caregivers and physicians. For more information, please visit www.RecognizeAlzheimersAgitation.com. Learn more about your ad choices. Visit megaphone.fm/adchoices

Sterling Johnson, PhD, Associate Director and Biomarker Core Leader in the Wisconsin Alzheimer’s Disease Research Center (ADRC), and a Clinical Neuropsychologist and Neuroscientist focused on understanding AD-related changes in the brain, details his research into the use of plasma p-tau217 as a blood-based biomarker for detecting Alzheimer disease. Learn more about your ad choices. Visit megaphone.fm/adchoices

Nicolas Villain, MD, PhD, Associate Professor of Neurology, Sorbonne University, Paris, France, discusses the International Working Group’s updated diagnostic criteria for the diagnosis and staging of Alzheimer disease, which offer an alternative definitional view of AD as a clinical-biologic construct. Learn more about your ad choices. Visit megaphone.fm/adchoices